Learn how to select a winning IPO team in our latest eBook. Download Now

Westicke Partners

Close

Posts by Victoria Meissner, M.D.

Victoria Meissner

Victoria Meissner, M.D., is a Vice President on Westwicke’s life sciences team. She has extensive experience in investor relations, capital raising, crisis communications, regulatory approval, and corporate strategy. She has an M.D. from the Medical University of Vienna and Ph.D. in microbiology and immunology from the University of Illinois at Chicago.

Keys to Successful Disclosure of Clinical Trial Data and Milestones

Posted on November 21st, 2019. Posted by

Clinical Disclosure

For publicly traded healthcare companies, clinical trial data and milestone disclosure can present great opportunities as well as significant challenges.

On the path toward regulatory approval, life science and medical device company management will encounter difficult disclosure decisions surrounding clinical and regulatory events. Finding the right balance between the “duty to disclose” vs. “pressure to disclose” dilemma is not easy. If done right, such milestones are a great way to raise visibility within the investment, clinical and scientific communities. If done wrong, the consequences may be severe.

Continue Reading

Guide to Selecting a Winning IPO Team

Going public? Learn how to identify the right people to work with your company by downloading our latest eBook, Guide to Selecting a Winning IPO Team.

Our Locations